PXMD (PaxMedica) OCF Margin %: 0.00% (As of Sep. 2024)


What is PaxMedica OCF Margin %?

PaxMedica PXMD OCF Margin % is 0.00% as of Sep. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. PaxMedica's Cash Flow from Operations for the three months ended in Sep. 2024 was $-0.63 Mil. PaxMedica's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, PaxMedica's OCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, PaxMedica's current OCF Yield % is -12,093.65%.

The historical rank and industry rank for PaxMedica's OCF Margin % or its related term are showing as below:


PXMD's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

PaxMedica OCF Margin % Related Terms

PaxMedica OCF Margin % Historical Data

* Premium members only.

The historical data trend for PaxMedica's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PaxMedica OCF Margin % Chart

PaxMedica Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PaxMedica Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PaxMedica OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

PaxMedica's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-10.769/0
= %

PaxMedica's OCF Margin for the quarter that ended in Sep. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.632/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
PaxMedica (PXMD) has a OCF Margin % of 0.00% as of Sep. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PaxMedica and its competitors.
Is PaxMedica's OCF Margin % too high?
PaxMedica's current OCF Margin % is 0.00%.
How does PaxMedica's OCF Margin % compare to BTAX and NBIO?
PaxMedica's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PaxMedica and its competitors. PaxMedica's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PaxMedica stock overvalued right now?
PaxMedica (PXMD) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PaxMedica (PXMD), the current OCF Margin % is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PaxMedica Business Description

Address 303 South Broadway, Suite 125, Tarrytown, NJ, USA, 10591
PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (COVID-19). The company's product candidate under development is PAX-101, an intravenous formulation of suramin, which it is developing for multiple indications, including East African HAT, ASD, ME/CFS, and LCS.